当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cervical cancer vaccine controversy in India
The Lancet Oncology ( IF 51.1 ) Pub Date : 2018-01-18 , DOI: 10.1016/s1470-2045(18)30018-4
Manjulika Das

India could prevent 70 000 deaths in women due to cervical cancer every year by introducing the human papillomavirus (HPV) vaccine in public health programmes, according to a media report.

中文翻译:

印度宫颈癌疫苗争议

据媒体报道,印度每年可以通过在公共卫生计划中引入人乳头瘤病毒(HPV)疫苗来预防因宫颈癌而导致的7万例妇女死亡。
更新日期:2018-02-01
down
wechat
bug